Allianz Asset Management GmbH lessened its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 4.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 169,099 shares of the health services provider's stock after selling 8,230 shares during the period. Allianz Asset Management GmbH owned about 0.30% of Maximus worth $11,531,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after acquiring an additional 205,564 shares in the last quarter. Mackenzie Financial Corp grew its stake in Maximus by 2.0% during the 4th quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock valued at $207,687,000 after acquiring an additional 55,583 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Maximus by 14.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after acquiring an additional 177,075 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in Maximus by 7.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after acquiring an additional 84,835 shares in the last quarter. Finally, Janus Henderson Group PLC grew its stake in Maximus by 2.0% during the 4th quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock valued at $88,546,000 after acquiring an additional 22,711 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Down 0.7%
NYSE:MMS traded down $0.51 on Wednesday, hitting $71.25. 361,858 shares of the company's stock traded hands, compared to its average volume of 394,607. The company has a market cap of $4.01 billion, a PE ratio of 14.17 and a beta of 0.61. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The firm has a 50-day moving average price of $71.30 and a 200-day moving average price of $70.61.
Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. The business had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm's revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.57 EPS. Equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.68%. Maximus's dividend payout ratio is 23.86%.
Insider Activity
In other news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Check Out Our Latest Report on Maximus
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.